Unique ID issued by UMIN | UMIN000047544 |
---|---|
Receipt number | R000054223 |
Scientific Title | Efficacy trial of single intake of plant derived ingredient on glucose metabolism. [n2017006] |
Date of disclosure of the study information | 2022/04/28 |
Last modified on | 2022/04/21 14:15:50 |
Efficacy trial of single intake of plant derived ingredient on glucose metabolism. [n2017006]
Efficacy of plant derived ingredient [n2017006]
Efficacy trial of single intake of plant derived ingredient on glucose metabolism. [n2017006]
Efficacy of plant derived ingredient [n2017006]
Japan |
Healthy adults
Not applicable | Adult |
Others
NO
To investigate effects of a plant derived ingredient on glucose metabolism in healthy male adults
Efficacy
Blood incretin concentration
Interventional
Cross-over
Randomized
Individual
Double blind -all involved are blinded
Placebo
YES
NO
NO
No need to know
3
Treatment
Food |
Control food consumption > wash out (1 week) > test food A consumption > wash out (1 week) > test food B consumption
test food A consumption > wash out (1 week) > test food B consumption > wash out (1 week) > Control food consumption
test food B consumption > wash out (1 week) > Control food consumption > wash out (1 week) > test food A consumption
20 | years-old | <= |
60 | years-old | > |
Male
(1)Healthy men
(2)Adult aged from 20 y to 60 y
(3)The person who can participate on the scheduled day
(4)The person who have given written informed consent prior to the study
(5)The person who can consume test foods
(6)The person who con record habitual lifestyle and diets
(1) Diabetes mellitus
(2) Having history or presence of cardiovascular disease or cerebrovascular disease
(3) Presence of liver, kidney or respiratory disease, endocrine disorder, metabolic disorder, organ disorder, gout, rheumatism, autoimmune disease, allergy disease, mental disorder, cancer, infection disease, or other diseases
(4) Having history of resection of gastrointestinal tract
(5) Thyroid deficiency
(6) Smoker
(7) Heavy alcohol drinker (over 30g per day)
(8) Donated over 200 mL of blood within the last one month prior to the study or over 400 mL of blood within the last three months prior to the study
(9) Severe anemia (Hb <=7g/dL)
(10) Feeling sick due to blood collection
(11) Food allergies for test meals
(12) Food allergies for test foods
(13) Cannot take all of the test food
(14) Planned to participate in other clinical study during current study
(15) Determined to be unqualified by the physician in charge or the responsible person of the study
20
1st name | Masanobu |
Middle name | |
Last name | Hibi |
Kao Corporation
Biological Science Research laboratories
131-8501
2-1-3, Bunka, Sumida-ku, Tokyo, 131-8501, Japan
03-5630-7476
hibi.masanobu@kao.com
1st name | Aya |
Middle name | |
Last name | Yanagimoto |
Kao Corporation
Biological Science Reseach Laboratories
131-8501
2-1-3, Bunka, Sumida-ku, Tokyo, 131-8501, Japan
03-5630-7476
yanagimoto.aya@kao.com
Kao Corporation
Kao Corporation
Profit organization
Human Research Ethics Committee, Kao Corporation
2-1-3, Bunka, Sumida-ku, Tokyo, 131-8501, Japan
+81-3-5630-7263
morisaki.naoko@kao.com
NO
2022 | Year | 04 | Month | 28 | Day |
Unpublished due to the protocol including the intellectual property rights
Published
works in progress
18
A significant difference was observed in the orimary outcome.
2022 | Year | 04 | Month | 21 | Day |
Healthy adults
18 participants completed and 18 subjects were incorporated into the analyses
None
Blood incretin
Main results already published
2017 | Year | 10 | Month | 17 | Day |
2017 | Year | 10 | Month | 17 | Day |
2017 | Year | 10 | Month | 18 | Day |
2018 | Year | 02 | Month | 13 | Day |
2018 | Year | 02 | Month | 13 | Day |
2018 | Year | 02 | Month | 13 | Day |
2019 | Year | 02 | Month | 18 | Day |
2022 | Year | 04 | Month | 21 | Day |
2022 | Year | 04 | Month | 21 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000054223